MX2007001029A - Agentes del receptor de histamina h3, preparacion y usos terapeuticos. - Google Patents

Agentes del receptor de histamina h3, preparacion y usos terapeuticos.

Info

Publication number
MX2007001029A
MX2007001029A MX2007001029A MX2007001029A MX2007001029A MX 2007001029 A MX2007001029 A MX 2007001029A MX 2007001029 A MX2007001029 A MX 2007001029A MX 2007001029 A MX2007001029 A MX 2007001029A MX 2007001029 A MX2007001029 A MX 2007001029A
Authority
MX
Mexico
Prior art keywords
methyl
ethyl
pyrrolidin
oxazol
phenyl
Prior art date
Application number
MX2007001029A
Other languages
English (en)
Spanish (es)
Inventor
Lisa Selsam Beavers
Terry Patrick Finn
Robert Alan Gadski
William Joseph Hornback
Cynthia Darshini Jesudason
Richard Todd Pickard
Freddie Craig Stevens
Serge Louis Boulet
Grant Matthews Vaught
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2007001029A publication Critical patent/MX2007001029A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MX2007001029A 2004-07-26 2005-07-14 Agentes del receptor de histamina h3, preparacion y usos terapeuticos. MX2007001029A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59119104P 2004-07-26 2004-07-26
PCT/US2005/024883 WO2006019833A1 (en) 2004-07-26 2005-07-14 Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses

Publications (1)

Publication Number Publication Date
MX2007001029A true MX2007001029A (es) 2007-04-12

Family

ID=35134220

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007001029A MX2007001029A (es) 2004-07-26 2005-07-14 Agentes del receptor de histamina h3, preparacion y usos terapeuticos.

Country Status (17)

Country Link
US (1) US7666871B2 (enExample)
EP (1) EP1786790B1 (enExample)
JP (1) JP4982367B2 (enExample)
CN (1) CN1989115B (enExample)
AT (1) ATE432926T1 (enExample)
AU (1) AU2005275183B2 (enExample)
BR (1) BRPI0513777A (enExample)
CA (1) CA2575081C (enExample)
CY (1) CY1109493T1 (enExample)
DE (1) DE602005014786D1 (enExample)
DK (1) DK1786790T3 (enExample)
ES (1) ES2325865T3 (enExample)
MX (1) MX2007001029A (enExample)
PL (1) PL1786790T3 (enExample)
PT (1) PT1786790E (enExample)
SI (1) SI1786790T1 (enExample)
WO (1) WO2006019833A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008301B2 (en) * 2004-04-01 2011-08-30 Eli Lilly And Company Histamine H3 receptor agents, preparation and therapeutic uses
EP1848428A4 (en) 2005-02-18 2012-04-18 Neurogen Corp THIAZOLE AMIDES, IMIDAZOLE AMIDES AND RELATED ANALOGS
JP2008534542A (ja) * 2005-03-31 2008-08-28 ユセベ ファルマ ソシエテ アノニム オキサゾール部分又はチアゾール部分を含む化合物、それらの製造方法及びそれらの使用
SI1954684T1 (sl) 2005-11-15 2014-07-31 Otsuka Pharmaceutical Co., Ltd. Oksazolna spojina in farmacevtski sestavek
MX2008011791A (es) 2006-03-15 2008-09-25 Wyeth Corp Azaciclilaminas-n-sustituidas como antagonistas de histamina-3.
WO2007134971A1 (de) * 2006-05-19 2007-11-29 Basf Se Benzoylsubstituierte alanine
AU2007254232A1 (en) 2006-05-19 2007-11-29 Wyeth N-benzoyl-and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
US8329159B2 (en) * 2006-08-11 2012-12-11 Bristol-Myers Squibb Company Hepatitis C virus inhibitors
PE20081152A1 (es) 2006-10-06 2008-08-10 Wyeth Corp Azaciclilaminas n-sustituidas como antagonistas de histamina-3
CL2008002088A1 (es) 2007-07-16 2008-09-05 Wyeth Corp Compuestos derivados de fenilo sustituido, moduladores del receptor de histamina 3; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de trastornos cognitivos tales como demencia, alzheimer, entre otros.
WO2009126782A1 (en) * 2008-04-11 2009-10-15 High Point Pharmaceuticals, Llc Histamine h3 receptor ligands
US8383829B2 (en) * 2008-04-15 2013-02-26 Konica Minolta Holdings, Inc. Electrochromic compound, electrode, and display element
SA110310332B1 (ar) 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
ES2527466T3 (es) 2010-07-06 2015-01-26 Astrazeneca Ab Agentes terapéuticos 976
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
CA2897279C (en) 2013-01-23 2020-12-29 Astrazeneca Ab Aminopyrazine derivatives and pharmaceutical compositions thereof for use in the treatment of cancer
WO2016097071A1 (en) * 2014-12-18 2016-06-23 F. Hoffmann-La Roche Ag Estrogen receptor modulators and uses thereof
PE20180506A1 (es) 2015-06-03 2018-03-09 Bristol Myers Squibb Co Agonistas de receptor de apelina (apj) de 4-hidroxi-3-(heteroaril) piridin-2-ona como para uso en el tratamiento de trastornos cardiovasculares
US20180194769A1 (en) 2015-07-06 2018-07-12 Rodin Therapeutics, Inc. Hetero-halo inhibitors of histone deacetylase
EP3319968A1 (en) 2015-07-06 2018-05-16 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
JP6756925B2 (ja) 2017-01-11 2020-09-16 ロダン・セラピューティクス，インコーポレーテッド ヒストンデアセチラーゼの二環式阻害剤
SMT202200232T1 (it) 2017-08-07 2022-07-21 Alkermes Inc Inibitori biciclici di istone deacetilasi

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3819037A1 (de) * 1988-06-04 1989-12-14 Hoechst Ag 2,4-disubstituierte oxazol-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als therapiemittel gegen krankheiten, die durch rhinoviren verursacht werden
CN1114834A (zh) * 1993-09-28 1996-01-10 大塚制药株式会社 抗糖尿病剂
AU3957600A (en) 1999-04-26 2000-11-10 Boehringer Ingelheim International Gmbh Piperidyl-imidazole derivatives, their preparations and therapeutic uses
WO2002076925A2 (en) 2001-03-23 2002-10-03 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
BR0306980A (pt) 2002-02-01 2004-11-09 Novo Nordisk As Composto, uso de um composto, composição farmacêutica, e, método para o tratamento de distúrbios ou doenças relacionadas com o receptor de histamina h3
US7332508B2 (en) * 2002-12-18 2008-02-19 Novo Nordisk A/S Substituted homopiperidine, piperidine or pyrrolidine derivatives
US7259262B2 (en) * 2003-10-24 2007-08-21 Hoffmann-La Roche Inc. Arylazole derivatives, their manufacture and use as pharmaceutical agents

Also Published As

Publication number Publication date
DE602005014786D1 (de) 2009-07-16
EP1786790B1 (en) 2009-06-03
CA2575081A1 (en) 2006-02-23
JP2008507579A (ja) 2008-03-13
SI1786790T1 (sl) 2009-10-31
DK1786790T3 (da) 2009-07-20
CN1989115B (zh) 2012-03-21
WO2006019833A1 (en) 2006-02-23
AU2005275183A1 (en) 2006-02-23
US20070197604A1 (en) 2007-08-23
BRPI0513777A (pt) 2008-05-13
CA2575081C (en) 2013-05-07
CY1109493T1 (el) 2014-08-13
AU2005275183B2 (en) 2011-03-17
PT1786790E (pt) 2009-08-18
ATE432926T1 (de) 2009-06-15
US7666871B2 (en) 2010-02-23
ES2325865T3 (es) 2009-09-22
JP4982367B2 (ja) 2012-07-25
EP1786790A1 (en) 2007-05-23
PL1786790T3 (pl) 2009-10-30
CN1989115A (zh) 2007-06-27

Similar Documents

Publication Publication Date Title
CA2575081C (en) Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
JP4942654B2 (ja) ヒスタミンｈ３受容体薬剤、製剤及び治療的使用
US11084784B2 (en) ROR-gamma modulators and uses thereof
CN101528717B (zh) 噻唑和*唑-取代的芳基酰胺类化合物
US6610696B2 (en) Modulators of peroxisome proliferator activated receptors
US7528160B2 (en) Fused heterocyclic derivatives as PPAR modulators
AU5731099A (en) Substituted oxazoles and thiazoles derivatives as hppar gamma and hppar alpha activators
WO2007126043A1 (ja) チアゾール環を含むカルボン酸誘導体の医薬用途
JP5318883B2 (ja) トリアゾ−ル置換アリールアミド誘導体およびｐ２ｘ３および／またはｐ２ｘ２／３プリン受容体アンタゴニストとしてのそれらの使用
AU2006228690A1 (en) Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses
CZ2004272A3 (cs) Perorální antidiabetická činidla
KR20030027054A (ko) 옥사졸릴-아릴프로피온산 유도체 및 ｐｐａｒ효능제로서의 그의 용도
MX2015002624A (es) Nuevas tiofenilamidas no anuladas como inhibidores de las proteinas de union a acido graso (fabp) 4 y/o 5.
WO2006049232A1 (ja) チアゾール環を含むカルボン酸誘導体およびその医薬用途
KR20120047960A (ko) 글루코키나아제(ｇｋ) 활성화제로서 치환된 벤즈아미드 유도체
CN1980906A (zh) 作为ppar调节剂的化合物和组合物

Legal Events

Date Code Title Description
FG Grant or registration